Brain volume loss linked to Alzheimer’s treatment may be caused by amyloid plaque removal

A loss of brain volume associated with new immunotherapies for Alzheimer’s disease may be caused by the removal of amyloid plaques, rather than the loss of neurons or brain tissue, finds a study led by UCL researchers.

Illumina to lay off 10% of research and development team in bid to cut costs by $100 million

SAN DIEGO — Months after announcing plans to cut costs by $100 million, DNA sequencing giant Illumina has begun to lay off 10% of its

June 26, 2023

Pain reliever use in pregnancy shows no link to child neurodevelopmental disorders, study finds

Extensive study explores acetaminophen use during pregnancy, analyzing its potential association with intellectual disability, ADHD, and autism in children, and ultimately finding no link when

April 11, 2024

Greenway Health, DrFirst Partner to Combat Prescription Abandonment

What You Should Know: – Greenway Health, a leading provider of electronic health record (EHR) solutions, and DrFirst, a health technology pioneer, have announced a

March 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.